Delivery Order SPE2DB20D1100-SPE2DB25FE4F1
- Not listed
- The Defense Logistics Agency awarded a $2,905.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a pharmaceutical product used in cardiovascular treatment. This competitive award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a child delivery order executed under a larger contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,615.05 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count units) on August 5, 2025, with completion expected by August 6, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, valued at $3,636.97. The award, made on August 26, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a $9,479.97 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,227.00 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,265.42 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $4,969.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a quantity of 60 units. The contract was competitively awarded with no set-aside designation and is set for ultimate completion on July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,457.28 for Corlanor 5 mg tablets (60-count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Corlanor 5 mg tablets (60-count units) with a ceiling value of $7,155.48 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award involved...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Corlanor 5 mg tablets (60-count) with a ceiling value of $3,296.56. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4F1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,992.45 to supply 60 tablets of Corlanor 7.5 mg, a pharmaceutical product used in the treatment of heart failure. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical supplies to support military healthcare systems and other federal agencies. The company's role as a Pharmaceutical Prime Vendor enables it to fulfill diverse medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 9/3/25 |